IM
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
8.726
Exchange
XNAS - Nasdaq
1.634
Last period Financial Leverage ,USD
-90%
Financial Leverage has decreased in 5 years
What is Financial Leverage ?
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
See also ImmunoGen
Company Analysis
IMGN valuation, rating, competitors, insights and company profile
Eyestock Rating
IMGN financial analysis by Eyestock methodology
Valuation
IMGN valuation using historical relative method
Statements
IMGN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IMGN dividend yield and annual dividend
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
ImmunoGen`s Financial Leverage for the last twelve months ended 2023-09-30 is 1.634
